Pia Fondazione Di Culto E Religione Card G Panico
- Address
- lock Available on a paid plan
Pia Fondazione Di Culto E Religione Card G Panico - Multidisciplinary Clinical Research Center
Pia Fondazione Di Culto E Religione Card G Panico is a comprehensive clinical research institution conducting advanced therapeutic trials across multiple medical specialties. The center demonstrates particular expertise in oncology research, with a focus on precision medicine approaches and novel targeted therapies for cancer treatment. Their research portfolio spans from gastrointestinal malignancies to hematologic cancers and neurodegenerative diseases, reflecting a commitment to addressing diverse and challenging medical conditions.
- Colorectal cancer with molecularly selected targeted therapies and preoperative treatment strategies
- Hematologic malignancies including relapsed/refractory diffuse large B-cell lymphoma (DLBCL) with combination immunotherapy approaches
- Alzheimer's disease and mild cognitive impairment utilizing advanced intrathecal drug delivery systems
- Hepatocellular carcinoma employing combination immunotherapy and anti-angiogenic treatments
The center's research methodology encompasses window-of-opportunity trials, umbrella platform studies, and dose-response evaluations, demonstrating proficiency in modern adaptive trial designs. Their participation in international multicenter studies, particularly focusing on biomarker-driven patient selection and personalized treatment approaches, positions them at the forefront of precision medicine. The institution's involvement in neurodegenerative disease research, specifically investigating cerebrospinal fluid delivery methods for Alzheimer's treatments, highlights their capability in complex interventional studies requiring specialized expertise.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 10 therapeutic areas and 15 of 129 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 124 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 27 by active trials.
- 1Fondazione GONO G.I.7active
lock +26 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Fondazione GONO G.I.11trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pia Fondazione Di Culto E Religione Card G Panico
lock Showing 1 of 85 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP) | Acadia Pharmaceuticals Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 129 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 19 | Unknown | 2019-01-03 | 2026-07-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.